ClinicalTrials.Veeva

Menu

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Viatris logo

Viatris

Status

Completed

Conditions

Glaucoma, Open-angle

Treatments

Drug: Xalacom

Study type

Observational

Funder types

Industry

Identifiers

NCT00801437
A6641053

Details and patient eligibility

About

This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma

Full description

according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD

Enrollment

457 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary open angle glaucoma
  • ocular hypertension
  • age >18 years

Exclusion criteria

  • bradycardia
  • obstructive pulmonary disease
  • hypersensitivity to the drug

Trial design

457 participants in 1 patient group

Xalacom treatment
Description:
patients with primary glaucoma
Treatment:
Drug: Xalacom

Trial contacts and locations

39

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems